Provided by Tiger Trade Technology Pte. Ltd.

GeneDx Holdings

73.95
+1.652.28%
Volume:189.95K
Turnover:14.03M
Market Cap:2.19B
PE:-20.32
High:75.38
Open:72.77
Low:72.20
Close:72.30
52wk High:170.87
52wk Low:32.21
Shares:29.68M
Float Shares:20.46M
Volume Ratio:0.75
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6399
EPS(LYR):-0.7339
ROE:-40.80%
ROA:-7.89%
PB:8.99
PE(LYR):-100.76

Loading ...

GeneDx Holdings Price Target Raised to $83.00/Share from $74.00 by Guggenheim

Dow Jones
·
1 hour ago

GeneDx price target raised to $83 from $74 at Guggenheim

TIPRANKS
·
2 hours ago

GeneDx selloff after CMS news ‘probably too extreme,’ says Craig-Hallum

TIPRANKS
·
Sep 22

GeneDx falls -5.4%

TIPRANKS
·
Sep 22

GeneDx, Beren Therapeutics launch NPC GenomeComplete

TIPRANKS
·
Sep 09

GeneDx and Beren Therapeutics Launch Npc Genomecomplete to Improve Diagnosis of Niemann-Pick Disease Type C

THOMSON REUTERS
·
Sep 09

GeneDx announces data published in Genetics in Medicine on genome sequencing

TIPRANKS
·
Aug 24

GeneDx Study Supports Hospital-Wide Rapid Genome Sequencing Adoption at Seattle Children’s

Reuters
·
Aug 24

Genedx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children

Reuters
·
Aug 11

GeneDx launches new online offering to expand accessibility of exome testing

TIPRANKS
·
Aug 11

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

THOMSON REUTERS
·
Aug 11

Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Aug 07

GeneDx to Present at Canaccord Genuity Growth Conference Fireside Chat

Reuters
·
Aug 07

GeneDx Holdings Price Target Maintained with a $90.00/Share by BTIG

Dow Jones
·
Aug 04

GeneDx Holdings Corp : Canaccord Genuity Raises Target Price to $90 from $75

THOMSON REUTERS
·
Aug 04

GeneDx Holdings Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

CORRECTION: GeneDx Hldgs Q2 Adj. EPS $0.01 Beats $(0.19) Estimate, Sales $114.440M Beat $111.011M Estimate

Benzinga Earnings
·
Aug 04

GUIDANCE: (WGS) GeneDX Expects 2026 Revenue Range $475 Million - $490 Million, vs. FactSet Est of $478.4 Million

MT Newswires Live
·
Aug 04

GeneDx Q2 FY26 GAAP Net Loss Widens to $17.7 Million; Revenue Rises 11% Year over Year to $114.4 Million

Reuters
·
Aug 04

GeneDx Q2 Revenue Beats Analyst Estimates

Reuters
·
Aug 04